Page 4 - Biological E News Today

It added that for the end-user, the price would be Rs.400 a dose, including taxes and administration charges.

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. 

No patent. no strings attached. indonesia, bat swan that, and biological e in india, they have, in clinical trials, look at superiority study to the astrazeneca oxford vaccine. there is no limit to the amount you can produce. throughout the southern hemisphere, you have that capacity. so they have already got 150 million doses ready to go. they will now produce 100 million doses a month. they will produce a billion doses. and the irony is our small research institute at texas childrens hospital,...

Companies in south africa. theyll have a billion over the next year, and we will have exceeded the global commitment of the u.s. government just with our research and student collaboration with biological e, so were really excited to make that difference. >> incredible work, dr. hotez. congratulations to you and your colleague. thanks so much for joining us. >> thanks sto much, pam. as people try to return home from the holidays, a spike in omicron infections and airlines are cancelling flight...

Your nomination. its not the pfizer-moderna vaccine. can you explain what youre work on? >> yeah, this is from our texas childrens center for vaccine development at baylor college of medicine, where weve been developing global health vaccines for more than two decades, mostly vaccines for parasittic diseases. but we took on coronavirus vaccines about a decade ago and have developed a low-cost vegan vaccine made of yeast, similar to the hepatitis b vaccine. it looks really promising. weve provide...

To the hepatitis b vaccine. it looks really promising. weve provided it with no patent, no strings attached to producers in india, bangladesh, and now southern africa. india is the furthest along, where they have 250 million doses. theyre known as biological e and theyve now released the vaccine through the emergency use regulation. i think this will be an important step to vaccinate the world because it checks so many boxes for what you want for a global health vaccine. >> after all that, you w...

Biological E and the Indian government will work together with WHO and their partners to develop a roadmap for producing mRNA vaccines as soon as possible. At present, India has no Covid-19 vaccine made on mRNA platform.

Bio E already manufactures a number of critical vaccines, including Corbevax, a second-generation vaccine for COVID-19.

What to do with all that extra production capacity built up when the pandemic was at its height?

Covid Vaccine India,Covid Vaccine 12 To 14 Age Group,Covid Vaccine Booster Shot Above 60 Years, corbevax,vaccine, Biological E, Corbevax, coronavirus, covid-19, pandemic, covid vaccination,coronavirus vaccine,corbevax,biological E,children vaccine, covid adolescent vaccination,covid vaccination